Skip to content

Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Type
Blogs Testimonial
Sectors (1)
Agriculture Biotech Chemicals Cosmetics Diagnostics Digital Health Food and Feed Healthcare Medical Devices Pharmaceuticals
Expertises (2)
Advertising and Claims Commercial Contracts Corporate, Governance and Boardroom Counselling Data Protection, (Cyber)security and AI Due Diligence Environmental and Sustainability Financing and M&A Intellectual Property and Licensing Litigation Regulatory Compliance and Enforcement Spin-out and Starter Advisory Subsidies and Grants
Pharmaceuticals Remove filter Commercial Contracts Remove filter Data Protection, (Cyber)security and AI Remove filter Clear all

5 results

Newest first
Newest first Oldest first A–Z Z–A
Pharmaceuticals Commercial Contracts Intellectual Property and Licensing Testimonial

Axon supports pharmaceutical companies in licensing their products across Europe and beyond. We draft and negotiate licence agreements tailored to each market, helping clients maximise the value of their intellectual property.

Healthcare Medical Devices Pharmaceuticals Data Protection, (Cyber)security and AI Testimonial

What distinguishes our lawyers is the ability to see the whole regulatory picture. We have assisted multiple clients, ranging from CROs to pharma start-ups to medical device manufacturers, in setting up GDPR compliance processes and agreements that allow for seamless interaction with other legal frameworks such as MDR and IVDR.

Pharmaceuticals Commercial Contracts Testimonial

We have negotiated clinical trial agreements on behalf of several sponsors.

Healthcare Pharmaceuticals Commercial Contracts Regulatory Compliance and Enforcement Testimonial

We have advised a client on collaborations between pharmaceutical companies and healthcare providers and contract research organisations, including the negotiation of framework agreements for clinical research.

Biotech Pharmaceuticals Commercial Contracts Intellectual Property and Licensing Testimonial

Axon advised a stock-listed biopharmaceutical company on antibody licensing and technology transfer agreements with two major US-based pharmaceutical companies. The deals involved the grant of commercial rights to the licensor's proprietary antibody platform technology.